NEW YORK, April 25, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding The Boeing Co. (NYSE: BA), Pentair, Inc. (NYSE: PNR), Northrop Grumman Corporation (NYSE: NOC), Omnicom Group Inc. (NYSE: OMC) and McKesson Corporation (NYSE: MCK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1661-100free.
The Boeing Co. Analyst Notes
On April 23, 2014, before market hours, Boeing Co. (Boeing) reported Q1 2014 financial results. The Company generated non-GAAP EPS of $1.76 on continued strong operating performance, while analysts polled by Thomson Reuters expected the Company to report earnings of $1.56 per share. Boeing's revenue increased 8.3% YoY to $20.5 billion reflecting higher commercial deliveries. Also, its operating cash flow increased significantly to $1.1 billion in Q1 2014. During the quarter, the Company repurchased 19.4 million shares for $2.5 billion. Boeing also lifted its 2014 core EPS guidance to between $7.15 - $7.35 from $7.00 - $7.20, to reflect the benefit of a tax settlement to be recognized in Q2 2014. The full analyst notes on Boeing are available to download free of charge at:
Pentair, Inc. Analyst Notes
On April 22, 2014, Pentair Ltd. (Pentair) announced Q1 2014 sales of $1.7 billion, down 2.8% YoY. Adjusted earnings per diluted share were $0.73, versus $0.58 in Q1 2013 driven by the continued momentum in productivity and synergies. On a GAAP basis, the Company reported EPS of $0.59 compared to $0.25 per share in Q1 2013. The Company informed that the quarterly dividend effective for Q1 and Q2 2014 is $0.25 per share per quarter. The Company informed that it will seek shareholder approval for raising dividend to 30 cents for each of Q3 and Q4 of 2014, as well as Q1 and Q2 of 2015. Looking forward, the Company expects adjusted EPS in a range of $1.02 to $1.05 for Q2 2014, on projected revenues of about $1.95 billion. The full analyst notes on Pentair are available to download free of charge at:
Northrop Grumman Corporation Analyst Notes
On April 23, 2014, Northrop Grumman Corporation (Northrop Grumman) reported Q1 2014 earnings. The global security Company reported total sales of $5.8 billion for Q1 2014 down by 4.2% YoY. Q1 2014 total operating income increased to $845 million or 11.3% YoY, and operating margin rate increased 200 basis points to 14.4%. Q1 2014 net earnings were $579 million, or $2.63 per diluted share, beating average analysts earnings estimates of $2.15 per share, polled by Thomson Reuters. According to the Company, the higher operating income is mainly because of a $77 million improvement in net FAS/CAS pension adjustment. The Company repurchased 4.8 million shares of its common stock for $564 million in Q1 2014. In addition, the Company raised 2014 EPS guidance to $8.90 - $9.15 from the earlier $8.70 - $9.00. The full analyst notes on Northrop Grumman are available to download free of charge at:
Omnicom Group Inc. Analyst Notes
On April 22, 2014, Omnicom Group Inc. (Omnicom) announced that its worldwide revenue in Q1 2014 increased 3.0% YoY to $3.5 billion. The Company in its Q1 2014 earnings report stated that domestic revenue increased 4.0% YoY to $1.9 billion, while international revenue increased 1.9% YoY to $1.6 billion. Operating income increased to $382.7 million from $371.7 million in Q1 2013. Omnicom's adjusted net income for Q1 2014 was $208.1 million or $0.80 per share, as compared to $199.7 million or $0.76 per share for Q1 2013. Following the results release, stock of Omnicom fell by 2.27% and ended the trading session at $69.87 with a total of 2.60 million shares trading during the session. The full analyst notes on Omnicom are available to download free of charge at:
McKesson Corporation Analyst Notes
On April 21, 2014, McKesson Corporation (McKesson) announced that McKesson Health Solution's, Holly Toomey will be present at 6th Care Coordination Summit that will showcase next generation, collaborative approach to utilization management. According to the Company, Toomey's session, "Payer Provider Collaboration: Are We Ready for Clinical and Financial Decision Making at the Point of Decision?" will begin at 9:30 a.m. on May 7, 2014 at the Gaylord National Resort in National Harbor, Md. As per McKesson, Toomey will explore what payer-provider collaboration looks like and how actionable content and efficient workflows hold the keys to success and her session will demonstrate how current technologies help providers determine whether care is appropriate, what is the cost associated and even where it should be provided. The full analyst notes on McKesson are available to download free of charge at:
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review